Fox Run Management’s Collegium Pharmaceutical COLL Stock Holding History

Fox Run Management’s Portfolio COLL Stock Details COLL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$253K	Buy
2024 Q2	–	Sell
2024 Q1	$210K	Buy
2018 Q2	–	Sell
2018 Q1	$221K	Buy